Larimar Therapeutics Inc (LRMR)

Operating Cash Flow (Statement)

-$44.03M

Quarterly · Period ending: · USD

LRMR logo

LRMR Operating Cash Flow (Statement)

Latest reported-$44.03M
LRMR Quarterly Cash from Operations (-$11.09M → -$44.03M)
High-resolution chart · PNG

LRMR operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Larimar Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-44,030,000
-44,614,000
-38,527,000
-28,753,000
-19,381,000
-26,540,000
-21,815,000
-24,546,000
-13,988,000
-10,411,000
-9,343,000
-9,200,000
-7,365,000
-7,551,000
-6,672,000
-5,878,000
-7,486,000
-7,533,000
-7,918,000
-12,199,000
-10,782,000
-11,206,000
-9,857,000
-11,222,000
-12,199,000
-8,921,000
-7,911,000
-5,823,000
-3,150,000
-5,815,000
-38,222,000
-13,076,000
-13,265,000
11,679,000
-11,679,000
17,761,000
-17,761,000
-48,467,000
-11,087,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.